Skip to content

Impact of Expired Carbon Monoxide Measurement on Smoking Cessation of Pregnant Women

Impact of Expired Carbon Monoxide Measurement on Smoking Cessation of Pregnant Women - Tobacco Pregnancy Addictive Pregnant Women

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03842449
Acronym
T-CAFE
Enrollment
102
Registered
2019-02-15
Start date
2019-03-18
Completion date
2022-03-18
Last updated
2021-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking Cessation

Keywords

Tobacco, Pregnancy Addictive, Pregnant Women, Stop smoking

Brief summary

France is the country of Europe where the prevalence of pregnant women smokers is the highest (35.9% before pregnancy and in the 3rd quarter 21.8% in 2008). In the investigator's country, among the smokers of early pregnancy with the usual care, only 30% manage to stop during pregnancy. Maternal smoking during pregnancy is a clearly identified risk factor for the course of pregnancy and the unborn child. The measurement of carbon monoxide (CO) expired in pregnancy monitoring consultation is part of the recommendations of the consensus conference Pregnancy and Tobacco (ANAES, October 2004) and the parliamentary report on smoking by JL Touraine and D. Jacquat (Feb 2012). However, this recommendation has not entered the current practice. The research aims to justify the clinical relevance of this recommendation by demonstrating the positive impact of expired CO measurement on the rate of discontinuation during pregnancy.

Interventions

DIAGNOSTIC_TESTBabyCO

An expired CO measurement will be performed by BabyCO and the result will be returned to the smoking pregnant woman by the consultant.

OTHERBiological samples

The nature of the samples taken during the delivery are: * maternal blood, * cord blood * placenta fragment

Sponsors

University Hospital, Limoges
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

: Group of smoking pregnant women (N = 600): * Pregnant women declaring themselves smokers (at least one cigarette a day). * Aged at least 18 years old. * Consultant at Limoges University Hospital before the 24th week of amenorrhea. * Desiring to be followed for their entire pregnancy at the Children's. * Desiring to give birth at the Children's. * Accepting to participate in the study Group of strictly non-smoking pregnant women (N = 50): * Pregnant women : * Declaring not to be a smoker (to have been totally weaned for more than one year and to have smoked less than 100 cigarettes in her lifetime) before the beginning of the current pregnancy, and * Whose partner and family do not smoke, and * Not significantly exposed to tobacco (in their professional environment in particular), and * With a CO measurement expired \<3 ppm. * Aged at least 18 years old. * Consultant at Limoges University Hospital before the 24th SA. * Desiring to be followed for all their pregnancy and give birth at the Children's Hospital of Limoges. * Accepting to participate in the study.

Exclusion criteria

: Group of smoking pregnant women (N = 600) : * Women with the following social and / or legal criteria: guardianship, curatorship, safeguard of justice. * Women unable to understand the objectives of the study and the constraints of the protocol. Group of strictly non-smoking pregnant women (N = 50) : * Women with the following social and / or legal criteria: guardianship, curatorship, safeguard of justice. * Women unable to understand the objectives of the study and the constraints of the protocol. * Women with high blood pressure * Diabetic woman * Woman with hypothyroidism

Design outcomes

Primary

MeasureTime frameDescription
Smoking cessation on the date of birthDate of birthEvaluate the impact on maternal smoking cessation rate at birth of a strategy combining maternal expired CO measurement, restitution, and outcome comment initiated no later than at the 24th week of amenorrhea and conducted thoughout the whole pregnancy.

Secondary

MeasureTime frameDescription
Impact on maternal, placental and fetal exposure to the toxic and compounds of tobacco smoke.Date of birthImpact on maternal, placental and fetal exposure to the toxic and compounds of tobacco smoke measured in maternal, cordal blood and placenta by ICP-MS, GC-MS and LC-MS methods
Impact on the intention of breastfeeding on the date of birthDate of birthImpact on the intention of breastfeeding on the date of birth evaluated by a questionnaire
Predictive value of expired CO in relation to maternal-fetal exposure to these toxic and compoundsDate of birthDetermine the predictive value of expired CO in relation to maternal-fetal exposure to these toxic and compounds
Maternal expired CO on the day of birthDate of birthMaternal expired CO on the day of birth
Determinants of smoking cessation on the day of birthDate of birthPotential determinants of smoking cessation, including: age, parity, precariousness assessed by the EPICES score, history of smoking before pregnancy, expired CO measurement, etc.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026